m-pill.com homepage We subscribe to the HONcode principles of the HON Foundation. Click to verify.
 
 
m-pill.com homepage
We subscribe to the HONcode principles of the HON Foundation. Click to verify.
 
 
M-PILL.com Homepage / Press 
 
 
 
 Do you want to be called by us ?
Fill out the form below.


  Do you want to contact our team ?

 


Date : 27-06-2003
Title : « MOBILE PATIENT DIARY, INTERACTIVE PACKAGE SOLUTION »
Published in :

MOBILE PATIENT DIARY, INTERACTIVE PACKAGE SOLUTION

Brussels, Belgium - June, 2003

UNIQUE AND COMPLETE PAPER FREE ANSWER TO OPTIMIZE AND MONITOR PATIENT COMPLIANCE NOW AVAILABLE:
SYMFO LEADER IN ELECTRONIC PATIENT DIARY AND M-PLIFY A MOBILE MESSAGING ASP PROVIDER. ARE MOVING ONE STEP FURTHER INTO THEIR COLLABORATION AND LAUNCH THE 'MOBILE PATIENT DIARY, INTERACTIVE PACKAGE SOLUTION'

Patient self-reported data collected using the Symfo® Electronic Diary (S.E.D), combined with M-PLIFY's M-PILL mobile communication solution allows to obtain reliable data, faster, and to have interactive communication with the patient during the entire course of the trial.- The Symfo-M-PILL Mobile Patient Diary solution empowers patients feedbacks by allowing real time monitoring- .

Symfo's CEO Serge Bodart commented, "Symfo is very excited to be partnering with M-PILL. Poor compliance is one of the main limitations of paper diary. Using electronic diaries addressed the challenge of compliance but we realized that what was still missing, was an application that took into consideration the underlying behavioral dynamics of patients. The M-PILL mobile communication solution combined with the Symfo Electronic Patient Diary allows to record timely accurate data as well as monitor, facilitates, encourage and rewards subject adhesion to protocol in almost real time".

M-PLIFY's CEO Hubert Schumacher to add "Diaries should be easy to use for subjects and programmed reminders have consistently been found to improve compliance rate in clinical trial. By providing subjects with timely, real-time compliance incentives, the Mobile Patient Diary encourages the type of habit-forming interactions with the device. If the subjects know that their compliance is being tracked and they receive feedbacks, they report feeling more engaged with the study protocol."

About M-PLIFY
Symfo s.a., with its subsidiary Symfo (USA) Inc., (www.symfo.com) is a fast-growing international organization that developed a simple and affordable solution enabling users to easily implement Electronic Patient Diary in clinical trials and consumer product evaluation studies. For more information, please send an email at info@symfo.com.

About M-PLIFY
M-PLIFY (www.m-plify.com), a wireless technology company, focuses on developing and delivering mobile applications to the healthcare industry. Since "M-PILL", its mobile drug compliance tool, won the "Ericsson mobile application Award 2001", M-PLIFY has implemented this wireless solution across Europe in collaboration with leading pharmaceutical companies. M-PLIFY has also leveraged its technology expertise in order to roll out various customized mobile applications serving the needs of pharmaceutical companies, doctors and patients. For further information about the company or M-PILL contact contact@mpill.com or visit the site www.m-pill.com

Contact Info:

Luxembourg office
M-PLIFY S.A.
47, avenue de la Liberté
L-1931 Luxembourg
Tel: +352 261846-1
Fax: +352 261846-46
support@mpill.com
contact@mpill.com
Brussels office
M-PLIFY S.A.
c/o M-Village
42-44 rue des Palais
B-1030 Bruxelles
Tel: +32 2 2113418
Fax: +32 2 2188973
support@mpill.com
contact@mpill.com

 

Last modified: 27.05.2004
 

Quick Facts
What is medication non-Compliance ?
Are you at risk ?
A mobile medication reminder service, what for ?
Who needs the M-PILL service ?

M-PILL related links
M-PILL Pharma
M-PILL Clinical Trials
M-PILL Public
M-PILL Physicians
 
 
 
  Advertising &
Privacy Policy
     
Products & services  | FAQ  | About us  | Investors relations  | Press
Career  | Partners
Site Design www.synapse.lu